1. Home
  2. AKR vs AGIO Comparison

AKR vs AGIO Comparison

Compare AKR & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKR
  • AGIO
  • Stock Information
  • Founded
  • AKR 1993
  • AGIO 2007
  • Country
  • AKR United States
  • AGIO United States
  • Employees
  • AKR N/A
  • AGIO N/A
  • Industry
  • AKR Real Estate Investment Trusts
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AKR Real Estate
  • AGIO Health Care
  • Exchange
  • AKR Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • AKR 2.6B
  • AGIO 3.0B
  • IPO Year
  • AKR 1993
  • AGIO 2013
  • Fundamental
  • Price
  • AKR $25.00
  • AGIO $55.54
  • Analyst Decision
  • AKR Buy
  • AGIO Buy
  • Analyst Count
  • AKR 4
  • AGIO 7
  • Target Price
  • AKR $22.00
  • AGIO $52.33
  • AVG Volume (30 Days)
  • AKR 1.3M
  • AGIO 737.4K
  • Earning Date
  • AKR 10-28-2024
  • AGIO 10-31-2024
  • Dividend Yield
  • AKR 3.03%
  • AGIO N/A
  • EPS Growth
  • AKR N/A
  • AGIO N/A
  • EPS
  • AKR 0.10
  • AGIO 11.80
  • Revenue
  • AKR $367,395,000.00
  • AGIO $32,871,000.00
  • Revenue This Year
  • AKR N/A
  • AGIO $33.38
  • Revenue Next Year
  • AKR $7.26
  • AGIO $163.06
  • P/E Ratio
  • AKR $239.55
  • AGIO $4.70
  • Revenue Growth
  • AKR 7.51
  • AGIO 36.79
  • 52 Week Low
  • AKR $14.72
  • AGIO $20.96
  • 52 Week High
  • AKR $25.58
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • AKR 59.88
  • AGIO 62.15
  • Support Level
  • AKR $24.30
  • AGIO $52.09
  • Resistance Level
  • AKR $25.09
  • AGIO $62.58
  • Average True Range (ATR)
  • AKR 0.45
  • AGIO 2.85
  • MACD
  • AKR -0.04
  • AGIO -0.06
  • Stochastic Oscillator
  • AKR 55.68
  • AGIO 63.58

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company's portfolios are located primarily in metropolitan areas of the United States. The company operates through three segments: core portfolio, which consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon and generates the majority of total revenue; funds, which comprises the funds launched by the trust; and structured financing, which consists of notes receivable and related interest income.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Share on Social Networks: